The World Federation of Hemophilia (WFH) Annual Global Survey (AGS) was launched to standardize the collection of data on the global bleeding disorder population. The...
The 3rd edition of the World Federation of Hemophilia (WFH) Guidelines for the Management of Hemophilia is coming soon. This invaluable resource will offer up-to-date...
The WFH Virtual Summit: Connecting the Global Bleeding Disorders Community, being held from June 14 to 19, 2020, has been accredited by the European Accreditation...
A new commentary presenting the World Federation of Hemophilia (WFH) Gene Therapy Registry has been published in Haemophilia, the official journal of the WFH. The...
A new letter to the editor, published in Haemophilia, the official journal of the World Federation of Hemophilia (WFH), looks at how healthcare practitioners are...
In‐hospital management of persons with haemophilia and COVID‐19: practical guidance, authored by Cedric Hermans, MD, Medical member, WFH Board of Directors, has just been published...
The World Federation of Hemophilia (WFH) is monitoring the manufacturing, safety and supply of hemophilia therapies during the coronavirus pandemic. The WFH will be posting all...
A new report covering the second World Federation of Hemophilia (WFH) Gene Therapy Round Table (GTRT) has been published in Haemophilia, the official journal of...
A new article providing additional information on how people with hemophilia (PWH) will be impacted by the COVID‐19 pandemic has been published in Haemophilia, the...
Wiley—publisher of Haemophilia, the official journal of the World Federation of Hemophilia (WFH)—has made all COVID-19-related publications in Haemophilia freely available for everyone. To access...